PS.
PublicSupply

NP39724 Generic and Biosimilar Cancer Medicines

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)contractFind a Tender ↗Ref ocds-h6vhtk-04870b32014L0024active
View buyer

Estimated value

—

goods

Awarded value

—

Suppliers

77

Lots

43

43 awarded

Published

27 Feb 2025

Total lots

43

Awarded

43

0 pending

Estimated total

£66.4m

Awarded total

—

Lot 1cancelled

Bendamustine Powder For Solution For Infusion

Award value
—

Start

—

End

—

Estimated

£123k

CPV

33600000
Awarded to 1 supplier
AL
Accord-UK Ltd
Lot 2cancelled

Capecitabine Tablets

Award value
—

Start

—

End

—

Estimated

£724k

CPV

33600000
Awarded to 1 supplier
AL
Accord-UK Ltd
Lot 3cancelled

Carboplatin Injections

Award value
—

Start

—

End

—

Estimated

£677k

CPV

33600000
Awarded to 1 supplier
FK
Fresenius Kabi Ltd
Lot 4cancelled

Cisplatin Injections

Award value
—

Start

—

End

—

Estimated

£1.4m

CPV

33600000
Awarded to 1 supplier
PL
Pfizer Ltd
Lot 5cancelled

Cyclophosphamide Injection, Powder For Reconstitution

Award value
—

Start

—

End

—

Estimated

£305k

CPV

33600000
Awarded to 1 supplier
BH
Baxter Healthcare Ltd
Lot 6cancelled

Cytarabine Injections

Award value
—

Start

—

End

—

Estimated

£80k

CPV

33600000
Awarded to 1 supplier
AL
Accord-UK Ltd
Lot 7cancelled

Dacarbazine Injections

Award value
—

Start

—

End

—

Estimated

£258k

CPV

33600000
Awarded to 1 supplier
MP
medac Pharma LLP
Lot 8cancelled

Disodium Folinate Injections

Award value
—

Start

—

End

—

Estimated

£291k

CPV

33600000
Awarded to 1 supplier
MP
medac Pharma LLP
Lot 9cancelled

Docetaxel Concentrate For Solution For Infusion

Award value
—

Start

—

End

—

Estimated

£264k

CPV

33600000
Awarded to 1 supplier
AL
Accord-UK Ltd
Lot 10cancelled

Doxorubicin Solution For Injection Vials

Award value
—

Start

—

End

—

Estimated

£65k

CPV

33600000
Awarded to 1 supplier
AL
Accord-UK Ltd
Lot 11cancelled

Fluorouracil 25MG/ML Injections

Estimated
£62k

Start

—

End

—

Estimated

£62k

CPV

33600000
No suppliers awarded yet for this lot.
Lot 12cancelled

Fluorouracil 50MG/ML Injections

Award value
—

Start

—

End

—

Estimated

£299k

CPV

33600000
Awarded to 1 supplier
AL
Accord-UK Ltd
Lot 13cancelled

Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials

Award value
—

Start

—

End

—

Estimated

£118k

CPV

33600000
Awarded to 1 supplier
FK
Fresenius Kabi Limited
Lot 14cancelled

Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials

Estimated
£50k

Start

—

End

—

Estimated

£50k

CPV

33600000
No suppliers awarded yet for this lot.
Lot 15cancelled

Gemcitabine Powder For Solution For Infusion Vials

Estimated
£240k

Start

—

End

—

Estimated

£240k

CPV

33600000
No suppliers awarded yet for this lot.
Lot 16cancelled

Idarubicin Hydrochloride Injection Powder For Reconstitution

Estimated
£106k

Start

—

End

—

Estimated

£106k

CPV

33600000
No suppliers awarded yet for this lot.
Lot 17cancelled

Ifosfamide Injection Powder For Reconstitution

Award value
—

Start

—

End

—

Estimated

£1.8m

CPV

33600000
Awarded to 1 supplier
DL
Day Lewis Medical Ltd
Lot 18cancelled

Irinotecan Hydrochloride Injections

Award value
—

Start

—

End

—

Estimated

£244k

CPV

33600000
Awarded to 1 supplier
FK
Fresenius Kabi Limited
Lot 19cancelled

Lanreotide Injection Prefilled Syringes (unbundled - without homecare)

Award value
—

Start

—

End

—

Estimated

£9.1m

CPV

33600000
Lot 20cancelled

Lanreotide Injection Prefilled Syringes (bundled - with homecare)

Award value
—

Start

—

End

—

Estimated

£9.1m

CPV

33600000
Lot 21cancelled

Methotrexate Without Preservatives Injections

Award value
—

Start

—

End

—

Estimated

£325k

CPV

33600000
Awarded to 1 supplier
MP
medac Pharma LLP
Lot 22cancelled

Methotrexate Oral Solution

Award value
—

Start

—

End

—

Estimated

£39k

CPV

33600000
Awarded to 1 supplier
RP
Rosemont Pharmaceuticals
Lot 23cancelled

Oxaliplatin Vial Solution

Award value
—

Start

—

End

—

Estimated

£157k

CPV

33600000
Awarded to 1 supplier
SP
Seacross Pharmaceuticals
Lot 24cancelled

Paclitaxel Concentrate For Intravenous Infusion

Award value
—

Start

—

End

—

Estimated

£442k

CPV

33600000
Awarded to 1 supplier
FK
Fresenius Kabi Limited
Lot 25cancelled

Temozolomide Capsules

Award value
—

Start

—

End

—

Estimated

£108k

CPV

33600000
Awarded to 1 supplier
RU
Ranbaxy UK Ltd
Lot 26cancelled

Vincristine Without Preservatives Injection

Award value
—

Start

—

End

—

Estimated

£112k

CPV

33600000
Awarded to 1 supplier
TU
Teva UK Ltd
Lot 27cancelled

Vinorelbine Injections

Award value
—

Start

—

End

—

Estimated

£40k

CPV

33600000
Awarded to 1 supplier
MP
medac Pharma LLP
Lot 28cancelled

Aprepitant Capsules

Estimated
£175k

Start

—

End

—

Estimated

£175k

CPV

33600000
No suppliers awarded yet for this lot.
Lot 29cancelled

Topotecan Capsules

Estimated
£53k

Start

—

End

—

Estimated

£53k

CPV

33600000
No suppliers awarded yet for this lot.
Lot 30cancelled

Topotecan Concentrate For Solution For Infusion

Award value
—

Start

—

End

—

Estimated

£6k

CPV

33600000
Awarded to 1 supplier
AL
Accord-UK Ltd
Lot 31cancelled

Octreotide Injections

Estimated
£108k

Start

—

End

—

Estimated

£108k

CPV

33600000
No suppliers awarded yet for this lot.
Lot 32cancelled

Filgrastim Pre-Filled Syringes

Award value
—

Start

—

End

—

Estimated

£188k

CPV

33600000
Awarded to 1 supplier
AL
Accord-UK Ltd
Lot 33cancelled

Pemetrexed Powder For Solution For Infusion Vials

Award value
—

Start

—

End

—

Estimated

£50k

CPV

33600000
Awarded to 1 supplier
SP
Seacross Pharmaceuticals
Lot 34cancelled

Pemetrexed (25Mg/Ml) Solution For Infusion Vials

Award value
—

Start

—

End

—

Estimated

£489k

CPV

33600000
Awarded to 1 supplier
AL
Accord-UK Ltd
Lot 35cancelled

Octreotide Powder And Solvent For Suspension For Injection Vials (unbundled - without homecare)

Award value
—

Start

—

End

—

Estimated

£850k

CPV

33600000
Awarded to 1 supplier
TU
Teva UK Ltd
Lot 37cancelled

Etoposide Injections

Estimated
£210k

Start

—

End

—

Estimated

£210k

CPV

33600000
No suppliers awarded yet for this lot.
Lot 38cancelled

Dasatinib Tablets

Award value
—

Start

—

End

—

Estimated

£467k

CPV

33600000
Lot 39cancelled

Range Generic & Biosimilar Cancer Medicines (unranked)

Award value
—

Start

—

End

—

Estimated

£8.8m

CPV

33600000
Lot 40cancelled

Idarubicin Hydrochloride Solution For Infusion Vials

Award value
—

Start

—

End

—

Estimated

£97k

CPV

33600000
Awarded to 1 supplier
PL
Pfizer Ltd
Lot 41cancelled

Range of Generic Cancer Medicines (single supplier)

Award value
—

Start

—

End

—

Estimated

£20.7m

CPV

33600000
Lot 42cancelled

Bosutinib Tablets

Award value
—

Start

—

End

—

Estimated

£3.5m

CPV

33600000
Awarded to 1 supplier
SU
STADA UK - Thornton & Ross
Lot 43cancelled

Paclitaxel Albumin Vials

Award value
—

Start

—

End

—

Estimated

£3.7m

CPV

33600000
Awarded to 2 suppliers
SU
STADA UK - Thornton & Ross
ZU
Zentiva UK
Lot 36cancelled

Octreotide Powder And Solvent For Suspension For Injection Vials (bundled - with homecare)

Award value
—

Start

—

End

—

Estimated

£643k

CPV

33600000
Awarded to 1 supplier
TU
Teva UK Ltd